Kenneth I. Maynard

Global Program Leader, CNS. Takeda Pharmaceuticals, Inc., USA

Kenneth I. Maynard serves as the Head of External Innovation in the Therapeutic Strategic Unit, at Sanofi-Aventis. Previously, he spent 5 years as a Project Director responsible for leading multifunctional teams in the clinical development of central nervous system (CNS) compounds and 5 years in CNS research as a Principal Scientist and Section Head for cerebrovascular disorders. Prior to joining the pharmaceutical industry, he worked as an Assistant Professor in surgery and neurosurgery at Harvard Medical School and as an Assistant Neuroscientist in the neurosurgical service, at Massachusetts General Hospital. He holds the B.S., M.S., and Ph.D. degrees in the areas of human sciences, neurological science, and neurobiology, respectively, from University College, London, UK. He serves in leadership roles as an Elected Fellow of the American Heart Association and the Society for Neuroscience. He also serves on the Executive Committee of the International Dose-Response Society. He has authored more than 45 scientific publications and serves on the editorial committees of the American Journal of Pharmacology and Toxicology, Current Neurobiological Research, Current Neurovascular Research, and Recent Patent Reviews on CNS Drug Discovery.

Biography Updated on 16 March 2011

Scholarly Contributions [Data Provided by ]